Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > share activity

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Aug 18, 2023 11:52am

214 Views

Post# 35594963

RE:RE:RE:share activity

Convertible debentures will work for companies with a strong balance sheet and investors have faith in the product and leadership. We seem to have a promising product, relatively unknown leadership and a negative balance sheet. Huge challenge for a successful Debenture financing.
Our immediate hope is for BTD approval and a JV with a major pharma. RDW is talking about another PP worrh 5 Million. We need more Data and a good quarterly report to generate any interest in a PP.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments